# Mettler Toledo (MTD) Financial Model Free Excel 3-statement financial model and company analysis for Mettler Toledo. - Canonical: https://finamodel.com/companies/mettler-toledo - Industry: Laboratory Equipment - Downloadable model: Yes - Excel download: https://finamodel.com/company-models/MTD.xlsx ## Model Purpose This model projects Mettler-Toledo International Inc.'s (MTD) three-statement financials and free cash flow to determine its intrinsic equity valuation and assess the sustainability of its aggressive share repurchase programme. ## Company Overview Mettler Toledo is a global manufacturer of precision instruments and services for use in laboratory, industrial, and food retailing applications. The company operates a highly profitable, asset-light business model with a significant recurring revenue stream from its global service network. Business segments: - Laboratory Instruments (approx. 56% of revenue) - Industrial Instruments (approx. 39% of revenue) - Retail Weighing Solutions (approx. 5% of revenue) Key geographies include the Americas (42%), Europe (29%), and Asia/Rest of World (29%). The company holds the global number-one market position in most of its product categories, benefiting from high switching costs and a massive installed base that drives recurring service revenue (which accounts for approximately 25% of total sales). ## Revenue Deep Dive ### Laboratory Instruments - Segment name: Laboratory Instruments - Revenue driver formula: Laboratory Volume Growth x Realised Pricing + Service Attachment Revenue - Historical growth rate: 4% to 7% CAGR - Key growth levers and headwinds: Bioproduction growth, pharmaceutical R&D spending, and automation trends; headwinds include biotech funding slowdowns and academic budget constraints. - Pricing dynamics: High pricing power due to the critical nature of precision measurement in compliance and quality control. - Revenue recognition notes: Equipment sales recognised upon delivery; service contracts deferred and recognised over the contract term. - Seasonality: Q4 is historically the strongest quarter due to year-end budget flushes in corporate and academic labs. ### Industrial Instruments - Segment name: Industrial Instruments - Revenue driver formula: Industrial Volume Growth x Realised Pricing + Service Attachment Revenue - Historical growth rate: 3% to 5% CAGR - Key growth levers and headwinds: Supply chain automation, logistics investments, and product inspection needs; headwinds include global manufacturing PMIs and macroeconomic slowdowns. - Pricing dynamics: Value-based pricing tied to efficiency gains and waste reduction for manufacturers. - Revenue recognition notes: Standard equipment recognised upon delivery; complex integrated systems may use percentage-of-completion. - Seasonality: Less pronounced than the laboratory segment, but generally stronger in the second half of the year. ### Retail Weighing Solutions - Segment name: Retail Weighing Solutions - Revenue driver formula: Retail Volume Growth x Realised Pricing + Service Attachment Revenue - Historical growth rate: 0% to 2% CAGR - Key growth levers and headwinds: Supermarket upgrades and networked scale adoption; headwinds include grocery margin pressures and long replacement cycles. - Pricing dynamics: Highly competitive market with lower pricing power compared to laboratory instruments. - Revenue recognition notes: Recognised upon delivery and installation. - Seasonality: Q3 and Q4 are typically stronger ahead of the holiday shopping season. ## Cost Structure ### Variable Costs / COGS - COGS includes raw materials, manufacturing overhead, direct labour, tariff costs, and service personnel expenses. - Gross margin range: 58.0% to 60.5% (59.4% in 2025). - Key input costs: Electronic components, metals, and global freight. - How COGS scales with revenue: High gross margins mean incremental volume drops cleanly to the bottom line, though recent tariff increases have pressured margins slightly. ### Operating Expenses - R&D: Typically 4.5% to 5.0% of revenue, focused on software (LabX), automation, and digital sensors. - SG&A: Typically 25.0% to 26.5% of revenue, heavily driven by the massive direct sales and service workforce (approx. 9,300 employees). - Depreciation & Amortisation: Low, typically 3.0% to 4.0% of revenue, reflecting the asset-light assembly nature of the business. - Stock-Based Compensation: Approx. 1.0% to 1.5% of revenue. - Restructuring / one-time charges: Infrequent, usually minor footprint consolidations. ### Margin Profile - Gross margin: 58.0% to 60.5% - EBITDA margin: 31.0% to 33.0% - Operating margin: 29.0% to 31.0% (29.6% adjusted in 2025) - Net margin: 21.0% to 23.0% - Margin trend: Historically expanding due to pricing power and mix shift towards higher-margin service revenue, though temporarily compressed in 2025 due to tariffs. ## Balance Sheet Structure - Total assets: Approx. $3.5 billion to $4.0 billion. - Key asset categories: Cash, accounts receivable, inventory, and goodwill. - Goodwill & intangibles: Represent a moderate portion of assets due to historical bolt-on acquisitions (e.g., PendoTECH). - Working capital profile: - Days Sales Outstanding (DSO): 35 to 45 days. - Days Inventory Outstanding (DIO): 40 to 50 days. - Days Payable Outstanding (DPO): 35 to 45 days. - Net working capital as % of revenue: Very low, often operating near zero or slightly negative, allowing the company to fund growth internally. - PP&E: Approx. $800 million, primarily final assembly and testing facilities. - Right-of-use assets / operating leases: Moderate, related to leased sales offices and service centres globally. ## Capital Expenditure & Investment - Capex as % of revenue: 2.5% to 3.5% (highly asset-light). - Maintenance capex vs. growth capex: Roughly 50/50 split, with growth capex focused on IT infrastructure, software development, and facility automation. - Major capex programmes: Smart Manufacturing approaches and global process standardisation (Blue Ocean). - Capitalised software: Material due to internal use software and customer-facing platforms like LabX. - M&A pattern: Occasional bolt-on acquisitions to acquire niche technologies. ## Debt & Capital Structure - Total debt: Approx. $2.3 billion. - Net debt: Approx. $2.2 billion (cash balances are kept minimal). - Debt/EBITDA ratio: 1.5x to 2.0x (conservative leverage). - Key debt instruments: Senior notes and a revolving credit facility. - Maturity profile: Well-laddered senior notes. - Interest rate profile: Mix of fixed-rate notes and floating-rate bank debt. - Share repurchase programme: Extremely active. The company uses almost 100% of its free cash flow to buy back shares, consistently reducing share count by 2% to 4% annually. - Dividend policy: The company does not pay a dividend. ## Cash Flow Characteristics - Operating cash flow conversion: Consistently >100% of net income due to high non-cash charges and tight working capital management. - Free cash flow margin: 21.0% to 24.0% of revenue ($878 million in 2025). - Major non-cash items: Depreciation, amortisation, and stock-based compensation. - Working capital cash flow impact: Generally neutral to a slight source of cash. - Capex intensity: Very low. - Cash tax rate vs. GAAP effective tax rate: Often lower than the statutory rate due to discrete tax benefits from stock option exercises and Swiss tax structures. ## Sheet Structure 1. **Assumptions**: Hardcoded drivers for macroeconomic inputs, segment growth rates, margin targets, and capital allocation policies. 2. **Revenue_Build**: Revenue projected separately for Laboratory Instruments, Industrial Instruments, and Retail Weighing Solutions. 3. **Income_Statement**: Consolidated P&L from Revenue down to Net Income and EPS, mirroring the 10-K format. 4. **Balance_Sheet**: Assets, Liabilities, and Shareholders' Equity. 5. **Cash_Flow_Statement**: Operating, Investing, and Financing cash flows, highlighting the massive share repurchase line item. 6. **Working_Capital**: Schedules for Accounts Receivable, Inventory, Accounts Payable, and Deferred Revenue. 7. **Debt_and_Interest**: Tranches of senior notes, revolver drawdowns, and interest expense calculations. 8. **Depreciation_Amortisation**: PP&E roll-forward, intangible asset amortisation, and capex schedules. 9. **Shareholders_Equity**: Retained earnings roll-forward and treasury stock tracking (critical for MTD due to buybacks). 10. **DCF_Valuation**: Unlevered free cash flow calculation, WACC build-up, terminal value, and implied share price. ## Key Financial Relationships 1. Laboratory Revenue = Prior Year Laboratory Revenue x (1 + Laboratory Growth Rate) 2. Industrial Revenue = Prior Year Industrial Revenue x (1 + Industrial Growth Rate) 3. Retail Revenue = Prior Year Retail Revenue x (1 + Retail Growth Rate) 4. Total Revenue = Laboratory Revenue + Industrial Revenue + Retail Revenue 5. COGS = Total Revenue x (1 - Gross Margin Percentage) 6. R&D Expense = Total Revenue x R&D Margin Percentage 7. SG&A Expense = Total Revenue x SG&A Margin Percentage 8. Operating Income = Total Revenue - COGS - R&D Expense - SG&A Expense 9. Free Cash Flow = Operating Cash Flow - Capital Expenditures 10. Share Repurchases = Free Cash Flow - Minimum Cash Balance Requirement + Net Debt Issuance 11. Ending Shares Outstanding = Beginning Shares Outstanding - (Share Repurchases / Average Share Price) 12. EPS = Net Income / Ending Shares Outstanding ## Cross-Sheet Dependencies - The **Revenue_Build** sheet feeds the top line of the **Income_Statement** and drives the activity levels in the **Working_Capital** sheet. - The **Income_Statement** generates Net Income, which is the starting point for the **Cash_Flow_Statement**. - The **Working_Capital** sheet calculates changes in operating assets and liabilities, feeding the **Cash_Flow_Statement**. - The **Cash_Flow_Statement** determines the cash available for share repurchases, which feeds the **Shareholders_Equity** sheet and reduces the share count on the **Income_Statement** for EPS calculations. - Circularity risk: Interest expense on the **Income_Statement** depends on the debt balance on the **Debt_and_Interest** sheet, which depends on the cash shortfall/surplus from the **Cash_Flow_Statement**, which in turn depends on Net Income. A circuit breaker toggle is required. ## Sign Convention - Revenue and Asset balances are positive. - Expenses (COGS, R&D, SG&A) are entered as positive numbers in their respective build schedules but subtracted in the Income Statement totals. - Liability and Equity balances are positive. - Cash inflows on the Cash Flow Statement are positive; cash outflows (including Capex and Share Repurchases) are negative. ## Things Most Likely to Go Wrong - Failing to account for the aggressive share reduction: MTD's EPS grows much faster than Net Income because of constant buybacks. The model must dynamically reduce share count. - Overestimating capital intensity: MTD is highly asset-light. Modelling capex too high will severely understate Free Cash Flow. - Ignoring foreign exchange impacts: MTD reports in USD but generates over 50% of revenue in Europe and Asia. The model should ideally evaluate constant currency growth rates. - Mismodelling gross margins: Tariffs and freight costs can swing gross margins by 50 to 100 basis points, which has a massive impact on operating profit due to low variable costs. - Overcomplicating the service revenue: MTD does not report Service as a standalone segment; it is embedded within Lab, Industrial, and Retail. Do not try to build a separate Service segment on the Income Statement. - Missing discrete tax benefits: MTD frequently reports non-cash discrete tax benefits (e.g., $0.95 per share in 2025). The effective tax rate should be normalised for forecasting. - Misunderstanding working capital: MTD operates with very tight, sometimes negative, working capital. Do not assume standard industry DSO/DIO ratios without checking historicals. - Ignoring shipping delays: Quarter-to-quarter revenue can be lumpy due to logistics provider issues. Focus on annualised trends. ## Validation Checks - Gross margin must remain between 58.0% and 61.0%. - Operating margin should be in the 29.0% to 31.0% range. - Free Cash Flow conversion (FCF / Net Income) must be >100%. - Capex as a percentage of revenue should not exceed 3.5%. - Debt to EBITDA should remain below 2.5x. - Total Assets must equal Total Liabilities plus Shareholders' Equity in all periods. - Share count must decrease year-over-year if Free Cash Flow is positive. - Effective tax rate should remain between 17.0% and 19.0% excluding discrete items. ## Key Assumptions (Default Values) | Assumption | Default Value | Unit | Rationale | |---|---|---|---| | Laboratory Instruments Growth | 4.0 | % | Reflects normalised growth in bioproduction and pharma R&D | | Industrial Instruments Growth | 3.0 | % | Aligns with long-term industrial automation trends | | Retail Weighing Growth | 1.0 | % | Mature market with slow replacement cycles | | Gross Margin | 59.5 | % | Blended average reflecting recent tariff pressures and pricing power | | R&D as % of Revenue | 4.8 | % | Consistent historical investment in software and digital sensors | | SG&A as % of Revenue | 25.5 | % | Reflects the cost of maintaining a massive global direct sales force | | Effective Tax Rate | 18.0 | % | Normalised rate excluding one-time discrete tax benefits | | Capex as % of Revenue | 2.8 | % | Asset-light manufacturing footprint | | DSO | 40 | Days | Based on historical receivables performance | | DIO | 45 | Days | Based on historical inventory management | | DPO | 40 | Days | Based on historical supplier payment terms | | Share Repurchase % of FCF | 95.0 | % | Management consistently returns almost all FCF via buybacks | | Cost of Debt | 4.5 | % | Weighted average interest rate on senior notes and revolver | | WACC | 8.5 | % | Standard discount rate for a stable, large-cap precision instruments firm | | Terminal Growth Rate | 3.0 | % | Aligns with long-term global GDP and inflation expectations | ## Data Sources & Benchmarks - SEC EDGAR: Mettler-Toledo International Inc. (MTD) 10-K and 10-Q filings. - Investor Relations: mt.com/investors for earnings presentations and transcripts. - Key Peers: Waters Corporation (WAT), Agilent Technologies (A), Thermo Fisher Scientific (TMO), PerkinElmer (PKI). - Industry Data: Global manufacturing PMIs, pharmaceutical R&D spending reports. - Consensus Estimates: FactSet or Bloomberg for forward-looking EPS and revenue estimates. ## Sources - Mettler-Toledo International Inc. 2024 and 2025 Annual Reports (Form 10-K) - Mettler-Toledo Q4 2025 Earnings Press Release and Financial Schedules - SEC EDGAR Database - Mettler-Toledo Investor Relations Website - Motley Fool: Mettler-Toledo International Stock Price & News - Seeking Alpha: Mettler-Toledo International Earnings Analysis --- ## Frequently asked questions ### What does Mettler Toledo do? Mettler Toledo is a global manufacturer of precision instruments and services for use in laboratory, industrial, and food retailing applications. The company also generates significant recurring revenue from its global service network, which accounts for approximately 25% of total sales. ### What are Mettler Toledo's main revenue streams? Mettler Toledo's revenue is primarily driven by its Laboratory Instruments segment, which accounts for approximately 56% of revenue, and Industrial Instruments, contributing about 39%. A significant portion of its total sales, around 25%, comes from recurring service revenue due to its massive installed base and global service network. ### What is Mettler Toledo's capital expenditure strategy? Mettler Toledo operates an asset-light business model, with capital expenditure typically ranging from 2.5% to 3.5% of revenue. This capex is roughly split between maintenance and growth, with growth investments focusing on IT infrastructure, software development, and facility automation. ### What is the purpose of the Mettler Toledo financial model? The Mettler Toledo financial model projects the company's three-statement financials and free cash flow. Its primary purpose is to determine MTD's intrinsic equity valuation and evaluate the sustainability of its aggressive share repurchase program. ### Can I download an Excel financial model for Mettler Toledo? Yes, an Excel financial model for Mettler Toledo (MTD) is available for download. This model projects the company's financials from FY2026 to FY2030 and includes key assumptions for revenue growth, margins, and capital expenditures. ### How does Mettler Toledo maintain its market position and profitability? Mettler Toledo holds the global number-one market position in most of its product categories, benefiting from high switching costs for customers. This, combined with a massive installed base, drives a significant recurring service revenue stream, contributing to its highly profitable and asset-light business model. [Interactive forecast calculator](https://finamodel.com/companies/mettler-toledo/forecast)